Financhill
Back

Pharming Group NV Stock Predictions

Pharming Group NV Stock Forecast

  • Over the next 52 weeks, Pharming Group NV has on average historically risen by 10.2% based on the past 5 years of stock performance.
  • Pharming Group NV has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Pharming Group NV Stock Undervalued?
    The current Pharming Group NV [PHAR] share price is $16.37. The Score for PHAR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PHAR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Pharming Group NV Stock Go Up Next Year?

  • Over the next 52 weeks, Pharming Group NV has on average historically risen by 10.2% based on the past 5 years of stock performance.

Pharming Group NV Stock Rating

Sell
32
Pharming Group NV (PHAR) is a Sell

Is Pharming Group NV overpriced?

  • Pharming Group NV has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Pharming Group NV Stock Price History

Is PHAR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Netherlands
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
pharming.com

52-Week Data

52-Week High:
21.34
52-Week Low:
7.50

Prediction Charts

Market Cap:
1.1B
Price in USD:
16.37
Volume:
23.5K
Beta:
0.01

Technical Analysis

SMA50:
17.50
SMA100:
16.47
SMA200:
14.18
52-Wk Change:
79%

Stock Predictions

  • Is Pharming Group NV stock public?
    Yes, Pharming Group NV is a publicly traded company.
  • What is the Pharming Group NV stock quote today?
    The Pharming Group NV stock price is 16.37 USD today.
  • How to buy Pharming Group NV stock online?
    You can buy Pharming Group NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-6 16.10 16.09 16.45 15.96
Feb-9 16.28 16.37 16.41 16.08
Feb-10 16.46 16.19 16.48 16.09
Feb-11 16.13 15.57 16.13 15.57
Feb-12 15.81 15.30 15.84 15.26
Feb-13 15.40 15.42 15.75 15.32
Feb-17 15.69 16.30 16.50 15.65
Feb-18 16.59 16.78 17.22 16.59
Feb-19 16.66 16.47 17.44 16.30
Feb-20 16.42 16.36 16.57 16.13
Feb-23 16.57 16.76 16.76 16.05
Feb-24 16.78 16.80 17.14 16.72
Feb-25 16.93 16.80 17.15 16.80
Feb-26 16.60 16.37 16.60 15.79

Pharming Group NV Earnings

Pharming Group NV Earnings Report: Per Share Pharming Group NV Earnings Q1 Q2 Q3 and Q4 last year and next year.

Pharming Group NV Forecast Revenue Growth

Pharming Group NV Stock Analysis: Historical quarterly revenues per share for Pharming Group NV and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.00 per share.

* Pharming Group NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.